Form 10-Q Regulus Therapeutics For: Sep 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. AAPL
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to Form 10-Q Regulus Therapeutics For: Sep 30

Regulus Therapeutics (RGLS) Tops Q3 EPS by 12c

November 6, 2015 8:23 AM EST

Regulus Therapeutics (NASDAQ: RGLS) reported Q3 EPS of ($0.25), $0.12 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $2.85 million.

For earnings history and earnings-related data on Regulus Therapeutics (RGLS) click here.

... More